Search
CRx-119
go.drugbank.com/drugs/DB05688ExperimentalCRx-119 is a novel synergistic combination drug candidate discovered using the CombinatoRx combination High Throughput Screening (cHTS(TM)) technology with potential therapeutic use in a broad range of
Sulfaperin
go.drugbank.com/drugs/DB13320ExperimentalCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseSulfametomidine
go.drugbank.com/drugs/DB13485ExperimentalCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseAPT3111
go.drugbank.com/drugs/DB06390ExperimentalAPT3111 is an investigational drug used to treat PNH (paroxysmal nocturnal haemoglobinurea).
Ethyl pyruvate
go.drugbank.com/drugs/DB05869InvestigationalCTI-01 (ethyl pyruvate) is a novel anti-inflammatory agent for the treatment of critical inflammatory conditions.
Contulakin-G
go.drugbank.com/drugs/DB05950ExperimentalIt is the synthetic form of a natural peptide extracted from the venom of the Conus Geographus sea snail.
Brolamfetamine
go.drugbank.com/drugs/DB01484ExperimentalIllicitCategories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeRO7300490
go.drugbank.com/drugs/DB17535InvestigationalRO7300490 is under investigation in clinical trial NCT04857138 (A Study to Evaluate Safety, Pharmacokinetics and Anti-tumor Activity of RO7300490, as Single Agent or in Combination With Atezolizumab in
Synonyms: RO 7300490, RO-73004901-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline
go.drugbank.com/drugs/DB08555ExperimentalThis compound belongs to the isoquinolines and derivatives. … This medication is known to target mitogen-activated protein kinase 10.
N(4)-Adenosyl-N(4)-methyl-2,4-diaminobutanoic acid
go.drugbank.com/drugs/DB03458ExperimentalThis compound belongs to the purine nucleosides and analogues. These are compounds comprising a purine base attached to a sugar.